Amgen reaches a fresh annual peak amid strong quarterly performance and renewed institutional accumulation. Major research firms revise price targets following operational outperformance and margin ...

Amgen (NasdaqGS:AMGN) and Kyowa Kirin have stopped all clinical trials of rocatinlimab after newly identified safety concerns. The companies cited potential links between OX40 pathway modulation and ...

Amgen’s investigational monoclonal antibody paired with chemotherapy significantly improved overall survival for patients in a phase 3 stomach cancer trial compared to chemotherapy alone, according to ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds of jobs and feature advanced automation and digital ...

Thousand Oaks-based Amgen acquires Dark Blue Therapeutics in an $840 million deal. Thousand Oaks-based Amgen Inc. on Jan. 6 announced it has acquired Oxford, U.K.-based Dark Blue Therapeutics Ltd., a ...

Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the second quarter of 2026. The dividend will be paid on June 5, 2026, to all stockholders of ...

Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from ...